The Top Line

June 17, 2022


Listen Later

While revenue reflects how well a company’s products are selling, profit is the financial metric that really matters. It tells investors how efficiently a company is managed and how healthy the business is overall. We’ve taken a look at these bottom line figures and compiled a list of the top 10 most profitable pharma companies. But that's not all. The FDA advisory committee meeting met last Thursday and Friday, and the stakes were high. Bluebird bio came away on top. The committee endorsed two of its gene therapy candidates. Lastly, we’re all celebrating here at Fierce because our team’s faces are plastered on billboards at BIO International Convention. And we sent one shoe-leather reporter on a wild goose chase to find them. 

To learn more about the topics in this episode: 

  • The top 10 most profitable pharma companies in 2021
  • Pfizer already agreed to delay supply of COVID-19 shots to EU, now the bloc wants more
  • GSK hails phase 3 win for RSV vaccine in older adults, sparking race to regulators
  • Rune Labs translates Apple Watch data into Parkinson's insights with FDA nod
  • Bluebird gene therapy overcomes safety worries to snag a win at FDA advisory panel
  • Bluebird scores 2nd straight win at high-stakes FDA gene therapy meeting
  • Amid FDA delay, Amylyx scores conditional ALS drug nod in Canada
  • Eli Lilly's Olumiant snags biopharma's first FDA green light for alopecia areata
  • Alnylam's next-gen RNA drug Amvuttra wins FDA approval—and a Pfizer showdown may await
  • Ekso Bionics nabs FDA exoskeleton clearance for multiple sclerosis rehabilitation
  • Pfizer gives up on Paxlovid in less vulnerable COVID patients after data fail to impress
  • The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. 

    See omnystudio.com/listener for privacy information.

    ...more
    View all episodesView all episodes
    Download on the App Store

    The Top LineBy Fierce Life Sciences

    • 3.8
    • 3.8
    • 3.8
    • 3.8
    • 3.8

    3.8

    8 ratings


    More shows like The Top Line

    View all
    HBR IdeaCast by Harvard Business Review

    HBR IdeaCast

    217 Listeners

    Marketplace by Marketplace

    Marketplace

    8,582 Listeners

    The McKinsey Podcast by McKinsey & Company

    The McKinsey Podcast

    387 Listeners

    Bloomberg Businessweek by Bloomberg

    Bloomberg Businessweek

    443 Listeners

    Odd Lots by Bloomberg

    Odd Lots

    1,771 Listeners

    Bold Names by The Wall Street Journal

    Bold Names

    1,450 Listeners

    The Long Run with Luke Timmerman by Timmerman Report

    The Long Run with Luke Timmerman

    124 Listeners

    The Readout Loud by STAT

    The Readout Loud

    316 Listeners

    Thoughts on the Market by Morgan Stanley

    Thoughts on the Market

    1,275 Listeners

    Barron's Streetwise by Barron's

    Barron's Streetwise

    1,526 Listeners

    Business Of Biotech by Ben Comer

    Business Of Biotech

    85 Listeners

    BioCentury This Week by BioCentury

    BioCentury This Week

    30 Listeners

    Raising Health by Andreessen Horowitz, a16z Bio + Health

    Raising Health

    143 Listeners

    Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

    Biotech Hangout

    10 Listeners

    Goldman Sachs The Markets by Goldman Sachs

    Goldman Sachs The Markets

    72 Listeners